Home > Insider Trading > Filing (0001179110-11-004975)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1080014	Theravance Inc	THRX	Pharmaceutical Preparations (2834)	943265960

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1302448	J Bradford Shafer	Theravance, Inc. 901 Gateway Boulevard South San Francisco CA 94080	Sr Vp, Gen. Counsel, Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-03-11	20,238	$22.76	346,825	No	4	S	Direct
Common Stock	Disposition	2011-03-11	6,451	$22.75	0	No	4	S	Indirect	by children's trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	by children's trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,750	Indirect	by child's trust
Common Stock	2,750	Indirect	by child's trust
Common Stock	2,750	Indirect	by child's trust

Footnotes

This transaction was executed in multiple trades at prices ranging from $22.67 to $22.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $22.67 to $22.80. The price reported above reflects the weighted average sale price.
Shares held in trust for the benefit of the children of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.
Shares held in trust for the benefit of a child of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.